Unknown

Dataset Information

0

Toward Oral Supplementation of Diamine Oxidase for the Treatment of Histamine Intolerance.


ABSTRACT: A new diamine oxidase (DAO-1) was discovered recently in the yeast Yarrowia lipolytica PO1f and investigated for its histamine degradation capability under simulated intestinal conditions. DAO-1 was formulated together with catalase as a sucrose-based tablet. The latter (9 × 7 mm; 400 mg) contained 690 nkat of DAO-1 activity, which was obtained from a bioreactor cultivation of a genetically modified Y. lipolytica with optimized downstream processing. The DAO-1 tablet was tested in a histamine bioconversion experiment under simulated intestinal conditions in the presence of food constituents, whereby about 30% of the histamine was degraded in 90 min. This amount might already be sufficient to help people with histamine intolerance. Furthermore, it was found that the stability of DAO-1 in a simulated intestinal fluid is influenced distinctively by the presence of a food matrix, indicating that the amount and type of food consumed affect the oral supplementation with DAO. This study showed for the first time that a microbial DAO could have the potential for the treatment of histamine intolerance by oral supplementation.

SUBMITTER: Kettner L 

PROVIDER: S-EPMC9268349 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6859183 | biostudies-literature
| S-EPMC7726047 | biostudies-literature
| S-EPMC5947167 | biostudies-literature
| S-EPMC6590243 | biostudies-literature
| S-EPMC8469513 | biostudies-literature
| S-EPMC8445614 | biostudies-literature
| S-EPMC9102523 | biostudies-literature
| S-EPMC8144954 | biostudies-literature
| S-EPMC8945898 | biostudies-literature
| S-EPMC4066097 | biostudies-literature